AU2003263480A8 - Oral pharmaceutical compositions of fenofibrate having high bioavailability - Google Patents

Oral pharmaceutical compositions of fenofibrate having high bioavailability

Info

Publication number
AU2003263480A8
AU2003263480A8 AU2003263480A AU2003263480A AU2003263480A8 AU 2003263480 A8 AU2003263480 A8 AU 2003263480A8 AU 2003263480 A AU2003263480 A AU 2003263480A AU 2003263480 A AU2003263480 A AU 2003263480A AU 2003263480 A8 AU2003263480 A8 AU 2003263480A8
Authority
AU
Australia
Prior art keywords
fenofibrate
pharmaceutical compositions
oral pharmaceutical
high bioavailability
bioavailability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003263480A
Other versions
AU2003263480A1 (en
Inventor
Rajiv Malik
Gowri Shankar Miriyala
Ajay Kumar Singla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2003263480A8 publication Critical patent/AU2003263480A8/en
Publication of AU2003263480A1 publication Critical patent/AU2003263480A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
AU2003263480A 2002-09-24 2003-09-24 Oral pharmaceutical compositions of fenofibrate having high bioavailability Abandoned AU2003263480A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN961DE2002 2002-09-24
IN961/DEL/2002 2002-09-24
PCT/IB2003/004162 WO2004028506A1 (en) 2002-09-24 2003-09-24 Oral pharmaceutical compositions of fenofibrate having high bioavailability

Publications (2)

Publication Number Publication Date
AU2003263480A8 true AU2003263480A8 (en) 2004-04-19
AU2003263480A1 AU2003263480A1 (en) 2004-04-19

Family

ID=32040231

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263480A Abandoned AU2003263480A1 (en) 2002-09-24 2003-09-24 Oral pharmaceutical compositions of fenofibrate having high bioavailability

Country Status (3)

Country Link
EP (1) EP1553928A1 (en)
AU (1) AU2003263480A1 (en)
WO (1) WO2004028506A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1827416A1 (en) * 2004-12-03 2007-09-05 Abbott Laboratories Pharmaceutical compositions
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
US20110097414A1 (en) * 2007-02-26 2011-04-28 Sandal Roshan Lal Pharmaceutical compositions comprising adsorbate of fenofibrate
EP2842547A1 (en) 2013-08-27 2015-03-04 Freund Pharmatec Ltd. Improved fenofibrate compositions
EP2878311A1 (en) 2013-11-27 2015-06-03 Freund Pharmatec Ltd. Solubility Enhancement for Hydrophobic Drugs
CN109481437B (en) * 2017-09-13 2020-12-18 北京福元医药股份有限公司 Losartan potassium pharmaceutical preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (en) * 1980-11-19 1986-01-10 Laruelle Claude
FR2758459B1 (en) * 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2783421B1 (en) * 1998-09-17 2000-11-24 Cll Pharma PROCESS FOR THE PREPARATION OF NOVEL GALENIC FORMULATIONS OF FENOFIBRATE, GALENIC FORMULATIONS OBTAINED BY SAID PROCESS AND THEIR APPLICATIONS
FR2795961B1 (en) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
FR2819720B1 (en) * 2001-01-22 2004-03-12 Fournier Lab Sa NEW FENOFIBRATE TABLETS
EP2087882A1 (en) * 2002-03-26 2009-08-12 Teva Pharmaceutical Industries Ltd. Drug microparticles

Also Published As

Publication number Publication date
EP1553928A1 (en) 2005-07-20
WO2004028506A1 (en) 2004-04-08
AU2003263480A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
PL375833A1 (en) Pharmaceutical formulations of modafinil
GB2389530B (en) Pharmaceutical compositions
GB0321607D0 (en) Manufacture of pharmaceutical compositions
PL356358A1 (en) Solid dosage form of someticone for oral administration
PL367180A1 (en) Stabilized oral pharmaceutical composition
AU2003296897A8 (en) Pharmaceutical formulations of camptothecine derivatives
GB0210397D0 (en) Pharmaceutical formulations
IL162118A0 (en) Pharmaceutical compositions containing an orally active taxane derivative
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
IL163931A (en) Derivatives of amino-methyl substituted tetracyline compounds and pharmaceutical compositions thereof
HK1078265A1 (en) Novel pharmaceutical formulations of modafinil
GB2391473B (en) Pharmaceutical compositions
HUP0400850A3 (en) Oral pharmaceutical compositions
IL166337A0 (en) Oral administration of calctionin
AU2003249105A1 (en) Processes for the preparation of oral dosage formulations of modafinil
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
GB2392093B (en) Pharmaceutical formulations
GB0202900D0 (en) Novel formulations of drugs
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
AU2003276688A1 (en) Pharmaceutical composition of metaxalone with enhanced oral bioavailability
GB0229258D0 (en) Medicinal compositions
HK1068277A1 (en) Pharmaceutical compositions comprising chelidonineor derivatives thereof
AU2003263480A8 (en) Oral pharmaceutical compositions of fenofibrate having high bioavailability
GB0213481D0 (en) Pharmaceutical compositions
IL153098A0 (en) Pharmaceutical compositions containing modafinil

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase